Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
COVID-19 vaccines
COVID-19 vaccines
Page 25 of 95
Newsletters
Should natural gas and nuclear play a part in the energy transition?
By
David Meyer
February 3, 2022
Commentary
How George Washington defeated a pandemic to save the American Revolution
By
Willard Sterne Randall
February 2, 2022
Newsletters
Pfizer has become one of the world’s most admired companies
By
David Meyer
and
Alan Murray
February 2, 2022
Well
Brain damage, hair loss, and fatigue: Everything we know about the long-term effects of COVID infections
By
Andrew Marquardt
February 2, 2022
Health
Here’s when to finally expect children under 5 to be eligible for a COVID vaccine
By
Andrew Marquardt
February 1, 2022
Newsletters
How the pandemic radically changed consumer behavior
By
David Meyer
and
Alan Murray
February 1, 2022
Commentary
Inequity in health care made the AIDS crisis worse. Why are we making the same mistake with COVID-19?
By
Jennifer Lotito
January 31, 2022
Health
Will we need Omicron-specific COVID vaccines? A leading virologist says the global system for flu shots could be a model to help us decide
By
Erika Fry
January 31, 2022
Health
Moderna COVID-19 vaccine gets full approval from the FDA
By
Matthew Perrone
and
The Associated Press
January 31, 2022
Commentary
The Supreme Court’s vaccine rebuke leaves CEOs in a bind
By
Adam Galinsky
January 31, 2022
Newsletters
The EV race is one of the most fascinating business stories of our times
By
David Meyer
and
Alan Murray
January 31, 2022
Health
Omicron’s BA.2 ‘stealth’ subvariant spreads even faster than the highly contagious original, U.K. and Denmark say
By
David Meyer
January 31, 2022
Magazine
Inside Moderna’s plan to battle Omicron and develop a booster that works against any future variants
By
Erika Fry
January 30, 2022
Finance
Omicron is making the unvaccinated rethink their opposition to the jab, a new six-country survey shows
By
Bernhard Warner
January 28, 2022
Politics
Pfizer CEO Albert Bourla and Europe’s leaders negotiated a vaccine megadeal by private text. Now those messages may come out
By
David Meyer
January 28, 2022
Most Popular
Economy
National debt crisis will be averted by governments 'mobilizing and encouraging' private wealth to fill budget holes,...
By
Eleanor Pringle
Economy
Ford workers told their CEO 'none of the young people want to work here.' So Jim Farley took a page out of the...
By
Sasha Rogelberg
C-Suite
What the CEO of the world's largest data center company—with 273 locations in 36 countries—predicts will drive the...
By
Diane Brady
and
Sharon Goldman